Tag: Dr. Colleen Jonsson


News

UTHSC Awarded $3.2 Million for Upgrades to Regional Biocontainment Laboratory

|

The University of Tennessee Health Science Center has been awarded $3.2 million from the National Institute of Allergy and Infectious Diseases (NIAID) to upgrade the equipment and infrastructure in the UTHSC Regional Biocontainment Laboratory (RBL) on the Memphis campus to enhance the university’s research of infectious diseases, including COVID-19. Colleen Jonsson, PhD, Van Vleet Professor… Read More


News

UTHSC Researchers Sweep UT President’s Awards Five Years in a Row

|
Colleen Jonsson, PhD

The University of Tennessee Health Science Center recently announced its third record-breaking year for research grant awards. This effort to increase research awards by 43% over five years to $122.3 million has had multiple drivers. The reorganization of the Office of Research led by Steve Goodman, PhD, vice chancellor for Research, has made the environment… Read More


News

Graduate Student Researchers Working to Unlock Secrets of SARS-CoV-2

|
PhD student researcher Mariah Taylor in the RBL

Graduate research assistant Mariah Taylor has had the chance to be in the middle of COVID-19 pandemic research in a way that few at her level have experienced. A student in the Biomedical Sciences program in the Department of Microbiology, Immunology and Biochemistry, Taylor is working in the UTHSC Regional Biocontainment Laboratory (RBL) to help… Read More


News

UTHSC Leaders Receive UT President’s Awards

|

Two leaders from the University of Tennessee Health Science Center, one an advocate for health equity and the other a researcher of highly pathogenic viruses, are among six employees honored with the 2021 UT President’s Awards announced today by President Randy Boyd during the UT Board of Trustees meeting at the UTHSC Memphis campus. Altha… Read More


News

UTHSC Researchers Identify Three Drugs As Possible Therapeutics for COVID-19

|
Colleen Jonsson, PhD

Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. Based on virtual and in vitro antiviral screening that began in the earlier months of… Read More


News

Virus Hunter: UTHSC’s Colleen Jonsson Seeks Answers to Treat Deadly Viruses, Including COVID-19

|

It’s 105 degrees in June in the jungle of Paraguay, and Colleen Jonsson and her students are hunting a killer. They’re sweating under heavy biosafety gear and working in a makeshift lab set up on the porch of a house owned by the World Wildlife Federation. Their elusive prey is the hantavirus, a rodent-borne disease… Read More